Orange Book product · Generic (ANDA)
VERAPAMIL HYDROCHLORIDE
VERAPAMIL HYDROCHLORIDE
At a glance
Jun 15, 2022
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 15, 2022
4 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
VERAPAMIL HYDROCHLORIDE
Strength
2.5MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 214653
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of VERAPAMIL HYDROCHLORIDE
- 1998VERELAN PMBrand (NDA)
NDA 020943 · AZURITY
- 1996COVERA-HSBrand (NDA)
NDA 020552 · PFIZER
- 1991CALAN SRBrand (NDA)
NDA 019152 · PFIZER
- 1990VERELANBrand (NDA)
NDA 019614 · AZURITY
- 1988CALANBrand (NDA)
NDA 018817 · PFIZER
- 1987ISOPTINBrand (NDA)
NDA 018593 · MT ADAMS
- 1984CALANBrand (NDA)
NDA 019038 · GD SEARLE LLC
- 1984VERAPAMIL HYDROCHLORIDEBrand (NDA)
NDA 018925 · EXELA PHARMA
- —ISOPTINBrand (NDA)
NDA 018485 · MT ADAMS
- 2025VERAPAMIL HYDROCHLORIDEGeneric (ANDA)
ANDA 219252 · ZYDUS LIFESCIENCES
- 2025VERAPAMIL HYDROCHLORIDEGeneric (ANDA)
ANDA 218218 · ASPIRO
- 2024VERAPAMIL HYDROCHLORIDEGeneric (ANDA)
ANDA 216471 · FRESENIUS KABI USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
